Latest News From BioPharmaChem
-
Eli Lilly secures exclusive rights to chronic pain treatment
05 June, 2019
American pharmaceutical company Eli Lilly has secured an exclusive licence for a non-opioid, non-addictive chronic pain treatment from Boston-based biotech company Centrexion Therapeutics.
-
US firm Biohaven Pharmaceuticals targets Irish tax base as it raises $300m
20 June, 2019
-
Boston Scientific Galway expands in to new facility
25 June, 2019
Boston Scientific Galway has officially opened a new facility at its Ballybrit site. The expansion facilitates increased capacity to support global product demand. The new facility is at the site of the former Digital building and the company is investing €60M in this phase of development, with over 250 people expected to be based in the new facility by the end of 2019. The opening of the new facility is part of a programme of celebrations for Boston Scientific’s 25th Anniversary in Galway.
-
Allergan 'committed to Ireland' following €55bn sale
28 June, 2019